The Efficiency of the Central Venous Catheter Care Protocol

Saglik Bilimleri Universitesi Gulhane Tip Fakultesi

Status

Enrolling

Conditions

Central Venous Catheter Exit Site Infection

Stem Cell Transplant Complications

Treatments

Procedure: CENTRAL VENOUS CATHETER CARE PROTOCOL

Study type

Interventional

Funder types

Other

Identifiers

NCT05705895

2021/51

Details and patient eligibility

About

The study aims to evaluate the effectiveness of a central venous catheter (CVC) care protocol, which was created using current guidelines, research results, and expert opinions, on developing CVC-related bloodstream infection in patients with hematopoietic stem cell transplantation (HSCT) until discharge.

Full description

Hematopoietic stem cell transplantation (HSCT) is one of the important treatment approaches that prolongs survival in patients with hematological malignancies, immunodeficiency and some solid tumors. Despite advances in the treatment process, reasons such as recurrence of the underlying disease, organ toxicities and infectious complications adversely affect treatment success. Reasons such as high-dose chemotherapy, frequent blood sampling, stem cell reinfusion, and total parenteral nutrition applied to HSCT patients increase the need for central venous catheter insertion. Although these tools are often necessary and useful in the bone marrow transplantation process, they also bring mechanical, embolic, and infectious complications.

Central venous catheters (CVC) are one of the main applications of modern clinical treatment. Reasons such as high-dose chemotherapy, frequent blood sampling, stem cell reinfusion, and total parenteral nutrition applied to HSCT patients increase the need for central venous catheter insertion. Although these tools are often necessary and valuable in the bone marrow transplantation process, they also bring mechanical, embolic, and infectious complications. The study aims to evaluate the effectiveness of a central venous catheter (CVC) care protocol, created using current guidelines, research results, and expert opinions, on developing CVC-related bloodstream infection in patients with hematopoietic stem cell transplantation (HSCT) until discharge.

This research is a pretest-posttest quasi-experimental clinical study. It is conducted with 60 patients between January 2022 and December 2023. The data is collected with Patient Information Form and Daily Patient Evaluation Chart. No application will be made to 30 patients in the control group, and catheter care will be provided to the patients of the intervention group in line with the CVC Care Protocol created by the researchers.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Being hospitalized by the Medical Oncology Clinic at in a training and research hospital to become an Autologous HSCT,
The patient has an 8F-size, two-lumen temporary CVC,
Over 18 years of age
There is no communication problem,
Agreeing to participate in the research voluntarily after being informed about the study,

Exclusion criteria

Using a vascular access method other than an 8F size two-lumen temporary CVC in the patient,
Refusal to participate in the research voluntarily after being informed about the study,
Identification of a different focus of infection in the patient.